Detalhe da pesquisa
1.
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccination.
Transpl Infect Dis
; 25(2): e14003, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748718
2.
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(2): 333-339, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27826061
3.
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
Eur J Haematol
; 99(3): 269-274, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618016
4.
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission.
Biol Blood Marrow Transplant
; 22(9): 1621-1626, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27178373
5.
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
Am J Hematol
; 90(9): 784-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059733
6.
Erratum to: Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation [Biol Blood Marrow Transplant 2017;23:333-339].
Biol Blood Marrow Transplant
; 23(6): 1040, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183535
7.
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Ann Hematol
; 91(12): 1937-43, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22893485
8.
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia.
Am J Hematol
; 92(4): E45-E47, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076884
9.
Risk Factors and Outcome of C. difficile Infection after Hematopoietic Stem Cell Transplantation.
J Clin Med
; 9(11)2020 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207616
10.
Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy.
Am J Hematol
; 89(9): 933-4, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861480
11.
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.
Exp Hematol
; 34(3): 389-96, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16543073
12.
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
Leuk Res
; 58: 31-38, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407515
13.
The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.
Haematologica
; 91(6): 825-8, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16704962
14.
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.
Haematologica
; 91(9): 1268-72, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16956831
15.
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
Haematologica
; 91(2): 258-61, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461315
16.
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant.
Am J Hematol
; 86(9): 790-2, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21830231
17.
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Oncotarget
; 6(30): 30212-21, 2015 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26338961
18.
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression.
Cytometry B Clin Cytom
; 59(1): 40-5, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15108169
19.
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
Cancer
; 117(10): 2156-62, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21523728
20.
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
Leuk Res
; 34(7): 942-5, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20122734